神经酰胺评分预测社区人群心血管风险。
Ceramide Scores Predict Cardiovascular Risk in the Community.
机构信息
Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.
Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1558-1569. doi: 10.1161/ATVBAHA.120.315530. Epub 2021 Feb 18.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Ceramide Scores Predict Cardiovascular Risk in the Community.
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1558-1569. doi: 10.1161/ATVBAHA.120.315530. Epub 2021 Feb 18.
2
Plasma Ceramides.
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.
3
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1240-1252. doi: 10.1161/ATVBAHA.118.312166.
4
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
Circulation. 2018 Oct 23;138(17):1819-1827. doi: 10.1161/CIRCULATIONAHA.118.033505.
5
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
BMC Med. 2019 Apr 3;17(1):72. doi: 10.1186/s12916-019-1306-9.
6
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):725-32. doi: 10.1161/ATVBAHA.114.304964. Epub 2015 Jan 22.
7
Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1872-9. doi: 10.1161/ATVBAHA.115.305365. Epub 2015 Jun 11.
8
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387.
9
Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Atherosclerosis. 2015 May;240(1):216-21. doi: 10.1016/j.atherosclerosis.2015.03.011. Epub 2015 Mar 14.
10
Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2854-2861. doi: 10.1161/ATVBAHA.118.311927.
引用本文的文献
1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets.
Cardiovasc Res. 2025 Aug 14;121(9):1345-1358. doi: 10.1093/cvr/cvaf093.
3
Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response.
J Lipid Res. 2025 Jun;66(6):100825. doi: 10.1016/j.jlr.2025.100825. Epub 2025 May 15.
4
The role of sphingolipids in heart failure.
Eur Heart J Open. 2025 May 2;5(3):oeaf035. doi: 10.1093/ehjopen/oeaf035. eCollection 2025 May.
5
Serum and plasma sphingolipids as biomarkers of chemotherapy-induced cardiotoxicity in female patients with breast cancer.
J Lipid Res. 2025 May;66(5):100798. doi: 10.1016/j.jlr.2025.100798. Epub 2025 Apr 5.
6
Ceramide in Coronary Artery Disease: Troublesome or Helpful Future Tools in the Assessment of Risk Prediction and Therapy Effectiveness?
Metabolites. 2025 Mar 1;15(3):168. doi: 10.3390/metabo15030168.
7
Plasma lipidomic alterations during pathogenic SIV infection with and without antiretroviral therapy.
Front Immunol. 2025 Mar 10;16:1475160. doi: 10.3389/fimmu.2025.1475160. eCollection 2025.
8
A Mendelian randomization study on associations between plasma lipidome, circulating inflammatory proteins, and erectile dysfunction.
Transl Androl Urol. 2024 Dec 31;13(12):2724-2734. doi: 10.21037/tau-24-378. Epub 2024 Dec 28.
9
Air pollution and coronary atherosclerosis.
Future Cardiol. 2025 Jan;21(1):53-66. doi: 10.1080/14796678.2025.2451545. Epub 2025 Jan 9.
10
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.
Diabetes Obes Metab. 2025 Mar;27(3):1488-1497. doi: 10.1111/dom.16156. Epub 2024 Dec 26.
本文引用的文献
1
Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors.
Clin Chim Acta. 2020 Dec;511:138-142. doi: 10.1016/j.cca.2020.10.005. Epub 2020 Oct 12.
2
The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.
J Gen Intern Med. 2020 Jun;35(6):1701-1708. doi: 10.1007/s11606-019-05361-4. Epub 2019 Oct 30.
3
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387.
4
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
5
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
6
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
7
Ceramides as Novel Disease Biomarkers.
Trends Mol Med. 2019 Jan;25(1):20-32. doi: 10.1016/j.molmed.2018.10.009. Epub 2018 Nov 23.
8
Plasma Ceramides.
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.
9
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.
J Am Heart Assoc. 2018 May 3;7(10):e007931. doi: 10.1161/JAHA.117.007931.
10
Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology?
JACC Cardiovasc Imaging. 2017 Aug;10(8):923-937. doi: 10.1016/j.jcmg.2017.05.007.
Zotero 插件